Donors are financing wars instead of disease prevention
For decades, the global effort against HIV represented one of humanity's more deliberate acts of collective care — transforming a death sentence into a manageable condition for millions. Now, as donor nations redirect their resources toward the financing of wars, that hard-won infrastructure faces a contraction of 30 to 40 percent, and the UN's AIDS agency warns that the 2030 elimination target may slip from reach. The High-Level Meeting on AIDS convening in New York this June carries both the weight of what has been built and the shadow of what is being quietly abandoned.
- Global HIV funding has collapsed by 30 to 40 percent in a single year, as donor nations divert resources toward military conflicts rather than disease prevention.
- UNAIDS executive director Winnie Byanyima warns this June's High-Level Meeting could be the last of its kind if political will and financial commitment are not urgently restored.
- Millions of people living with HIV face disrupted access to antiretroviral treatment and prevention services as clinics, testing programs, and care networks are stretched to breaking point.
- The 2030 goal of eliminating HIV as a public health threat — once considered achievable — is now genuinely imperiled by the scale and speed of the funding retreat.
- Brazil-led G20 health agreements and regional medicine production initiatives offer a partial counterbalance, demonstrating that South-South cooperation can reduce dependence on traditional donors.
- Whether the June 22–23 New York meeting produces binding pledges or merely performative reaffirmations will signal whether the world is still serious about finishing what it started.
Winnie Byanyima, executive director of UNAIDS, delivered a stark warning ahead of the High-Level Meeting on AIDS scheduled for late June in New York: without a dramatic reversal in political and financial commitment, this gathering could be the last of its kind. The reason is a funding crisis of striking proportions — resources dedicated to fighting HIV have contracted by 30 to 40 percent compared to 2023 levels. Byanyima was direct about the cause: donor nations are financing wars, and global health has been deprioritized as geopolitical tensions escalate.
The human cost is concrete. Clinics distributing antiretroviral drugs operate on tighter margins. Testing, counseling, and care networks grow fragile. Scientists searching for a cure face new constraints. The countries most dependent on UNAIDS programming cannot sustain their own prevention and treatment initiatives without international support. And the target that once seemed within reach — eliminating HIV as a public health threat by 2030 — now appears genuinely at risk.
The June 22–23 meeting, themed "United and Together to End AIDS," will bring together UN Secretary-General António Guterres, people living openly with HIV, and leading figures in the global response. Its stated purpose is to secure political commitments that keep the 2030 goal alive. But Byanyima's warning hangs over the proceedings: without a fundamental shift in how donors allocate resources, such meetings risk becoming performative — places where nations reaffirm aspirations they have already begun to abandon.
There are counterweights. During Brazil's G20 presidency in 2024, health ministers reached an agreement on equitable access to health technologies, catalyzing local medicine and vaccine production across participating countries. This South-South cooperation offers a partial buffer against donor withdrawal. But promising as these initiatives are, they cannot bridge a gap of 30 to 40 percent. What the coming months reveal — whether binding pledges replace rhetoric, whether military spending yields ground to global health — will determine whether Byanyima's warning proves prophetic.
Winnie Byanyima, the executive director of UNAIDS, stood before journalists in New York with a stark warning: the funding crisis threatening the global HIV response may have already claimed its most visible casualty. Speaking ahead of the High-Level Meeting on AIDS scheduled for late June, she suggested this could be the last such gathering the world convenes—at least not without a dramatic reversal in political will and financial commitment.
The numbers tell a story of retreat. In the past year alone, resources dedicated to fighting HIV have contracted by between 30 and 40 percent compared to 2023 budgets. That is not a modest adjustment or a temporary pause. It is a significant hollowing out of the infrastructure that has, over the past two decades, transformed HIV from a death sentence into a manageable chronic condition for those with access to treatment. Byanyima was direct about where the money went instead: donors are financing wars. As geopolitical tensions have escalated globally, international funding for disease prevention has been deprioritized in favor of military expenditures.
The consequence is not abstract. Without sustained international support, the countries that depend on UNAIDS programming cannot maintain their own prevention and treatment initiatives. Scientists searching for a cure face constraints. Clinics that distribute antiretroviral drugs operate on tighter margins. The infrastructure of testing, counseling, and care that has kept millions alive grows fragile. And the target that seemed within reach just years ago—eliminating HIV as a public health threat by 2030—now appears genuinely at risk.
The High-Level Meeting itself, scheduled for June 22 and 23 in New York, carries the theme "United and Together to End AIDS." UN Secretary-General António Guterres will attend, alongside people living openly with HIV and prominent figures in the fight against the virus. The stated purpose is to secure political commitments that would keep the 2030 goal alive. But Byanyima's warning suggests that without a fundamental shift in how donor nations allocate resources, such meetings may become increasingly performative—gatherings where countries reaffirm aspirations they have already begun to abandon in practice.
There are, however, counterweights to this grim trajectory. During Brazil's presidency of the G20 in 2024, health ministers forged an agreement aimed at more equitable access to health technologies. The initiative has catalyzed local production of medicines and vaccines in participating countries, reducing dependence on external funding and supply chains. This kind of South-South cooperation and regional self-sufficiency offers a partial buffer against the withdrawal of traditional donor support. It demonstrates that when countries commit to solving the problem themselves, progress is possible even amid global funding constraints.
But such initiatives, however promising, cannot fully compensate for a 30 to 40 percent reduction in overall resources. The gap is too large, and the need too urgent. What happens in the coming months—whether donor nations recommit to HIV funding, whether the June meeting produces binding pledges rather than rhetorical flourishes, whether the political calculus shifts away from military spending and back toward global health—will determine whether Byanyima's warning proves prophetic or whether the world finds its way back to the work that was already underway.
Notable Quotes
This may be the last edition of this event without renewed political commitment and international support— Winnie Byanyima, UNAIDS executive director
Donors are redirecting investments to finance wars rather than sustain HIV prevention and treatment programs— UNAIDS leadership
The Hearth Conversation Another angle on the story
Why would a UN agency director say this might be the last high-level AIDS meeting? That sounds like a threat.
It's not a threat—it's a diagnosis. She's saying that without real political commitment and funding, there's no point in convening these meetings anymore. You can't keep gathering to discuss a problem you've decided not to fund.
But HIV hasn't gone away. Millions of people still need treatment.
Exactly. The disease hasn't changed. What's changed is the world's attention and its willingness to pay for the response. When funding drops 30 to 40 percent in a single year, you're not making a strategic choice—you're abandoning the work.
Where did the money go instead?
Wars. Geopolitical conflicts. As tensions have escalated globally, donors have shifted resources from disease prevention to military spending. It's a choice, and it has consequences for people on antiretroviral therapy in countries that can't absorb the cuts.
Is there any good news in this story?
Yes. Brazil and other G20 countries are building local capacity to produce their own medicines and vaccines. That reduces dependence on external funding and creates some resilience. But it's not enough to replace what's been lost.
So what happens next?
The June meeting will show whether countries are willing to reverse course. If they commit real money and political will, the 2030 target is still possible. If not, Byanyima's warning becomes a prophecy.